Features of Internal Audit in Pharmaceutical Industry

Tsvetanova, Yulia (2014): Features of Internal Audit in Pharmaceutical Industry. Forthcoming in: Pharmacia , Vol. 61, No. 2 (2014): pp. 30-34.

Abstract

The review highlights the main features of internal audit by focus on distribution of medicinal products. Recent data suggest internal audit as an antidote to effects of economic recession. The present review reveals internal audit as a tool for competitiveness through implementation of good practices. The purpose of the review is to describe the advantages of internal audit in new institutional frame. The object of analysis is the distribution practice, and more concrete, the wholesale distributors. The analysis was perform by factor analysis and done in response to the tendency for outsource of distribution activities and practical interest in the use of internal audit by implementation of requirements and recommendations for good practices. The results showed that the internal audit in pharmaceutical industry is determinate by two factors: regulatory requirements and complexity of supply chain. The external and the internal environment define five features of internal audit in pharmaceutical industry.

• Item Type: MPRA Paper
• Language: English
• Keywords: internal audit, good practices, medicinal products
• Subjects: F - International Economics > F5 - International Relations, National Security, and International Political Economy > F53 - International Agreements and Observance ; International Organizations; I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health; M - Business Administration and Business Economics ; Marketing ; Accounting ; Personnel Economics > M4 - Accounting and Auditing > M42 - Auditing

References

Institute of Internal Auditors. International Professional Practices Framework. 2013.

European Commission. Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use. 2013.

McCormick, K. Quality and Regulatory Compliance. Butterworth-Heinemann, 2002.

Pharmaceutical Quality Group. Pharmaceutical Auditing. Monograph No. 5 (revised). 2001.

World Health Organization. WHO Expert Committee on specifications for pharmaceutical preparations. WHO Technical Report Series 957. Geneva, 2009. International Conference on Harmonisation. Guideline for Good Clinical Practice. 2002.

Wold Health Organization. Good Laboratory Practice (GLP) Handbook. Geneva, 2009.

Wold Health Organization. WHO good manufacturing practices for medicinal products: main principles. Geneva, 2011.

Wold Health Organization. WHO good distribution practices for pharmaceutical products. Geneva, 2010.

European Commission. Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products.

Brhlikova, P., I. Harper, A. Pollock. Good Manufacturing Practice in the Pharmaceutical Industry. Working Paper 3, prepared for the workshop on 'Tracing Pharmaceuticals in South Asia', 2-3 July 2007, University of Edinburgh.

Julin, A. ISO 9000, and the European Union. ISO 9000 + ISO 14000 News, Vol. 8, No. 5, September-October 1999, 8-16.

Stoimenova, A., G. Petrova. Quality management in the pharmaceutical industry: ISO 9001 vs. GMP. Medical Review, 48, 2012, №2, 59-66.

Stoimenova, A., A. Savova, M. Manova, G. Petrova. Quality management in pharmaceutical procurement: most frequent non-conformities in pharmaceutical wholesalers in Bulgaria, Biotechnol. & Biotechnol. Eq. 2013; 27 (5): 4193-4196.

Alkafaji, Y., S. Hussain, A. Khallaf, M. Majdalawieh. Characteristics of an Internal Audit Activity (Report I). The Institute of Internal Auditors. 2010.

Commission on Protection of Competition. Decision № 303/2006. Sofia, 2006.

Wallace, W., R. Kreutzfeldt. Distinctive characteristics of entities with an internal audit department and the association of the quality of such departments with errors. Contemporary Accounting Research, 7 (2), 1991, 485-512.

European Commission. Executive Summary of the Pharmaceutical Sector Inquiry Report. 2009.

Swinkels, W. Exploration of a theory of internal audit. University of Amsterdam, 2012.

Ministry of Health. Ordinance No 39 of 13 September 2007 on the principles and requirements for Good Distribution Practice. Sofia, 2007.

European Commission. Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use.

European Commission. Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use. 2012.

European Commission. Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance of pharmacovigilance activities provided for in Regulation (EC) No 726/2004 of the European Parliament and of the Council and Directive 2001/83/EC of the European Parliament and of the Council.